<div id="readability-page-1">11:12 AM EST, 12/22/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts started the week higher late Monday morning, rising 0.51% to 1,670.42 on the S&amp;P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical company Cellectis ( CLLS ) and biotech firm Evaxion ( EVAX ) , which climbed 8.7% and 4% respectively. They were followed by internet browser company Opera (OPRA) and pharmaceutical company Ascendis Pharma ( ASND ) , which advanced 3.7% and 2.6% respectively.The decliners from continental Europe were led by biopharmaceutical company DBV Technologies ( DBVT ) and medical device maker EDAP TMS ( EDAP ) , which fell 10.6% and 4.3% respectively. They were followed by brewing company Anheuser-Busch InBev ( BUD ) and pharmaceutical company Novo Nordisk ( NVO ) , which were down 1.5% and 0.3% respectively.From the UK and Ireland, the gainers were led by biopharmaceutical company Mereo BioPharma Group ( MREO ) and biotech firm Autolus Therapeutics ( AUTL ) , which rose 13.5% and 8.9% respectively. They were followed by biopharmaceutical company Akari Therapeutics ( AKTX ) and mining company BHP Group ( BHP ) , which were up 5.2% and 2.8% respectively.The decliners from the UK and Ireland were led by biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) and alcoholic beverage company Diageo ( DEO ) , which dropped 6.9% and 2.4% respectively. They were followed by biopharmaceutical company NuCana ( NCNA ) and biotech firm Trinity Biotech ( TRIB ) , which lost 2.3% and 0.5% respectively. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

AUTL

MREO

在美國交易的歐洲股票以美國存託憑證形式在標準普爾歐洲精選 ADR 指數上上漲了 0.51%。顯著上漲的公司包括 Cellectis 和 Evaxion，而 DBV Technologies 和 EDAP TMS 則是下跌的領頭羊。來自英國和愛爾蘭的 Mereo BioPharma Group 和 Autolus Therapeutics 實現了顯著的漲幅，而 Biodexa Pharmaceuticals 和 Diageo 則出現了下跌

在美國以美國存託憑證形式交易的歐洲股票在週一的交易中上漲